Downloads

https://doi.org/10.53941/ijctm.2025.100006
Devaraj, S., Krishnan, D., & Chen, X. Triglyceride-Glucose (TyG) Index in a Pediatric Non-Diabetic Cohort-Surrogate Marker of Insulin Resistance?. International Journal of Clinical and Translational Medicine. 2025, 1(1), 6. doi: https://doi.org/10.53941/ijctm.2025.100006
Volume 1, Issue 1, 2025
Copyright (c) 2025 by the authors.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Original Research Articles

Triglyceride-Glucose (TyG) Index in a Pediatric Non-Diabetic Cohort-Surrogate Marker of Insulin Resistance?

Sridevi Devaraj *, Daksha Krishnan and Xinpu Chen

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA

* Correspondence: sxdevara@texaschildrens.org

Received: 22 January 2025; Accepted: 13 February 2025; Published: 1 March 2025

Abstract: The incidence of diabetes and obesity has reached epidemic levels. Although insulin resistance is the key pathophysiological mechanism, several surrogate biomarkers of insulin resistance such as Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), have been proposed. In recent years, research on triglyceride-glucose (TyG) index as a useful marker for identifying cardio-metabolic risk, particularly in adults, has been on the rise. However, there is a paucity of data on the role of the TyG index in children and adolescents and the association of the TyG index with HOMA-IR and DEXA (dual-energy X-ray absorptiometry), especially in North America. Therefore, this study aims to investigate the role of the TyG index in children and adolescents, and explore the relationship between the TyG index and HOMA-IR and DEXA in North American children and adolescents. Forty-four lean and obese children and adolescents were recruited after obtaining informed consent, anthropometric and laboratory assessments. TyG index was significantly higher in obese children and adolescents than in their lean counterparts (p < 0.001) and correlated significantly with glucose, BMI, DEXA, triglycerides and HOMA-IR. Thus, this pilot study shows that the TyG index may serve as an excellent surrogate for assessing cardio-metabolic risk in pediatrics.

Keywords:

TyG index insulin resistance children pediatric marker

References

  1. Website IDF Diabetes Atlas. Available online: https://diabetesatlas.org/atlas/tenth-edition (accessed on 14 December 2024).
  2. DeFronzo, R.A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: The missing links. The Claude Bernard Lecture 2009. Diabetologia 2009, 53, 1270–1287. https://doi.org/10.1007/s00125-010-1684-1.
  3. Kurniawan, L.B. Triglyceride-Glucose Index as a Biomarker of Insulin Resistance, Diabetes Mellitus, Metabolic Syndrome, And Cardiovascular Disease: A Review. EJIFCC 2024, 35, 44–51.
  4. Adams-Huet, B.; Zubirán, R.; Remaley, A.T.; et al. The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States. J. Clin. Lipidol. 2024, 18, e518–e524. https://doi.org/10.1016/j.jacl.2024.04.130.
  5. Avagimyan, A.; Pogosova, N.; Fogacci, F.; et al. Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine. Int. J. Cardiol. 2024, 418, 132663. https://doi.org/10.1016/j.ijcard.2024.132663.
  6. Guerrero-Romero, F.; Simental-Mendía, L.E.; González-Ortiz, M.; et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J. Clin. Endocrinol. Metab. 2010, 95, 3347–3351. https://doi.org/10.1210/jc.2010-0288.
  7. Vasques, A.C.; Novaes, F.S.; de Oliveira Mda, S.; et al. TyG index performs better than HOMA in a Brazilian population: A hyperglycemic clamp validated study. Diabetes Res. Clin. Pract. 2011, 93, e98–e100. https://doi.org/10.1016/j.diabres.2011.05.030.
  8. Song, K.; Park, G.; Lee, H.S.; et al. Comparison of the Triglyceride Glucose Index and Modified Triglyceride Glucose Indices to Predict Nonalcoholic Fatty Liver Disease in Youths. J. Pediatr. 2022, 242, 79–85. https://doi.org/10.1016/j.jpeds.2021.11.042.
  9. Chang, P.S.; Chang, P.F.; Lin, Y.C. Usefulness of the Triglyceride Glucose Index to Predict Nonalcoholic Fatty Liver Disease in Children with Obesity. J. Pediatr. 2023, 25, 260–261. https://doi.org/10.1016/j.jpeds.2022.12.010.
  10. Yoon, J.S.; Shim, Y.S.; Lee, H.S.; et al. A population-based study of TyG index distribution and its relationship to cardiometabolic risk factors in children and adolescents. Sci. Rep. 2021, 11, 23660. https://doi.org/10.1507/endocrj.EJ21-0560.
  11. Gounden, V.; Devaraj, S.; Jialal, I. The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes. Lipids Health Dis. 2024, 23, 416. https://doi.org/10.1186/s12944-024-02412-6.